Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,579 | -65,561 | -48,477 | -32,933 | -284,232 |
| Depreciation Amortization | 1,012 | 660 | -80 | -474 | 4,869 |
| Accounts receivable | -6,737 | -15,958 | 5,962 | -24,685 | 3,433 |
| Accounts payable and accrued liabilities | 14,512 | -8,705 | -7,977 | -13,587 | -15,514 |
| Other Working Capital | -117,459 | -69,680 | -66,490 | -34,054 | -119,687 |
| Other Operating Activity | 18,252 | 51,711 | 17,905 | 46,445 | 96,110 |
| Operating Cash Flow | $-137,999 | $-107,533 | $-99,157 | $-59,288 | $-315,021 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,628 | -8,628 | -8,628 | -8,628 | -245,101 |
| PPE Investments | 780 | 715 | -40 | -29 | -2,519 |
| Sale Of Investment | 133,841 | 132,183 | 132,183 | 59,933 | 400,621 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 656 |
| Investing Cash Flow | $125,993 | $124,270 | $123,515 | $51,276 | $153,657 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 74,078 |
| Debt Repayment | -40 | -36 | -20 | -12 | -484 |
| Common Stock Issued | 139 | 116 | 116 | N/A | 52,138 |
| Other Financing Activity | -354 | -340 | -229 | -153 | -2,983 |
| Financing Cash Flow | $-255 | $-260 | $-133 | $-165 | $122,749 |
| Exchange Rate Effect | 751 | 838 | 2,801 | 223 | -3,397 |
| Beginning Cash Position | 113,688 | 113,688 | 113,688 | 113,688 | 155,700 |
| End Cash Position | 102,178 | 131,003 | 140,714 | 105,734 | 113,688 |
| Net Cash Flow | $-11,510 | $17,315 | $27,026 | $-7,954 | $-42,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,999 | -107,533 | -99,157 | -59,288 | -315,021 |
| Capital Expenditure | -266 | -125 | -43 | -29 | -2,519 |
| Free Cash Flow | -138,265 | -107,658 | -99,200 | -59,317 | -317,540 |